Tag: manufacturing
World ADC San Diego 2023: What to Expect
The past few years saw significant progress in the treatment of cancer and hematological malignancies through antibody-druf conjugates (ADCs), with numerous approvals and positive...
Project Optimus: How to Prepare for Success
For some time now, cancer drug developers have known “Project Optimus” and new dose optimization expectations are coming their way from the Food and...
Novasep Expands HPAPI Manufacturing Capacity for the Production of Innovative Targeted...
Novasep, a leading supplier of services and technologies for the life sciences industry, expands its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities in...
Piramal Pharma Solutions and Bolt Biotherapeutics Sign Production Agreement
Piramal Pharma Solutions, a contract development and manufacturing organization (CDMO) and San Francisco-based biotech Bolt Bioterapeutics have signed a production agreement in which Piramal...
Emerging Trends in Single-Use Technology in the Manufacturing of Antibody-Drug...
Single-use technology, designed for the manufacturing of biopharmaceutical products, has made major inroads over the last 30 years. First introduced in the late 1970s...
Lonza Expands Manufacturing Capacity for ADC Payloads
Lonza, a specialty contract development and manufacturing (CDMO) partner to the biopharma industry, will add new highly potent API (HPAPI) manufacturing suites at its...
Benefitting from the Worldwide Supply Chain in the development of Antibody-drug...
Timing is everything.
Just over a decade ago, the pharmaceutical industry and R&D in China was dominated by generics and plagued with insufficient technical capacity...
Evolution of Antibody-Drug Manufacturing
Antibody-drug Conjugates (ADCs) have evolved since the initial approval of gemtuzumab ozogamicin (Mylotarg®) in 2000, with respect to conjugation, linker and toxin chemistries and...
ADC Biotechnology Invests in New Bioconjugation Facility in North Wales, United...
UK-based ADC Biotechnology has secured investment for the construction of an $11 million* bioconjugation facility at its new site in Deeside, North Wales, UK.
The...
Evolving CMC Analytical Techniques for Biopharmaceuticals
1.0 Abstract
During the (early) preclinical drug development process as well as manufacturing of biopharmaceutical (protein) products, analysis and characterization are crucial in gaining a...
